Systemic Immune–Inflammatory Indices in Gout: Clinical AND Prognostic Value with Emphasis on the Systemic Immune-Inflammatory Index (SII)
Year: 2025
Type: article
Abstract: Gout is a chronic crystal-induced inflammatory disease characterized by recurrent flares and persistent hyperuricemia. Traditional inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are commonly used to assess disease activity, yet they often fail to reliably reflect subclinical inflammation or predict long-term outcomes. In recent years, systemic immune–inflammatory indices (SIIs)—including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and particularly the systemic immune-inflammatory index (SII)—have emerged as promising biomarkers. This article provides a detailed analysis of the clinical and prognostic significance of these indices in gout, focusing on the SII as a comprehensive marker integrating neutrophil, platelet, and lymphocyte counts. The work summarizes pathophysiological mechanisms, diagnostic value, prognostic utility, correlation with comorbidities, and the potential role of SII in personalized treatment strategies.
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7159554374